Triazole-Engineered Ionizable Lipids with Tunable Headgroups for Efficient mRNA Delivery and Protective Immunity
ACS Nano Medicine · 05.11.2026
DOI: 10.1021/acsnanomed.6c00226 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 05.11.2026. Verfasst von Sourav Baidya und 11 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have emerged as a revolutionary nonviral platform for administering a wide range of therapeutics, especially nucleic acids. Expanding the diversity of lipid structures, which includes a variety of headgroups, linkers, and tail structures, offers exciting possibilities for developing novel lipid-based drug delivery systems. Consequently, the scientific community laid a greater emphasis on combinatorial methodologies for designing different libraries of ionizable lipid molecules. Herein, we are proposing the synthesis of a library of triazole-based ionizable lipids by using alkyne-azide click chemistry. Systematic variation of the terminal headgroup produced distinct mRNA expression profiles despite broadly comparable encapsulation efficiencies and physicochemical properties. LNP formulated using CL-3, containing primary amine headgroup, exhibited the highest in vitro mRNA expression and outperformed the benchmark ionizable lipids ALC-0315 and SM-102 under the conditions tested. CL-3-based LNPs elicited the highest binding-antibody titers among the evaluated formulations, while pseudovirus-neutralizing activity was comparable to that of the ALC-0315 benchmark. The immunized animals were protected in the mouse viral-challenge model under the conditions investigated. These findings identify CL-3 as a promising candidate within the evaluated lipid series and demonstrate the utility of modular synthesis for investigating structure–activity trends in mRNA delivery.
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
- Department of Biotechnology, Ministry of Science and Technology, India
- Ministry of Education, India
Zitieren
APA
Baidya, S., Sarmah, S., Nag, M., Chakraborty, D., Behera, P., Bharadwaj, K., Rajmani, R. S., Chatterjee, A., Sharma, C., Ringe, R. P., Varadarajan, R., & De, M. (2026). Triazole-Engineered Ionizable Lipids with Tunable Headgroups for Efficient mRNA Delivery and Protective Immunity. ACS Nano Medicine. https://doi.org/10.1021/acsnanomed.6c00226
Vancouver
Baidya S, Sarmah S, Nag M, Chakraborty D, Behera P, Bharadwaj K, et al. Triazole-Engineered Ionizable Lipids with Tunable Headgroups for Efficient mRNA Delivery and Protective Immunity. ACS Nano Medicine. 2026. doi:10.1021/acsnanomed.6c00226
BibTeX
@article{Baidya2026,
author = {Baidya, Sourav and Sarmah, Sharat and Nag, Manish and Chakraborty, Debajyoti and Behera, Pradipta and Bharadwaj, Krishna and Rajmani, Raju S. and Chatterjee, Arnab and Sharma, Chanchal and Ringe, Rajesh P. and Varadarajan, Raghavan and De, Mrinmoy},
title = {Triazole-Engineered Ionizable Lipids with Tunable Headgroups for Efficient mRNA Delivery and Protective Immunity},
journal = {ACS Nano Medicine},
year = {2026},
doi = {10.1021/acsnanomed.6c00226}
}
EUVIMED